Adenylyl Cyclase Inhibitors/administration & dosageAdenylyl Cyclase Inhibitors/adverse effectsAdenylyl Cyclase Inhibitors/analysisAdenylyl Cyclase Inhibitors/bloodAdenylyl Cyclase Inhibitors/cerebrospinal fluidAdenylyl Cyclase Inhibitors/chemical synthesisAdenylyl Cyclase Inhibitors/classificationAdenylyl Cyclase Inhibitors/economicsAdenylyl Cyclase Inhibitors/historyAdenylyl Cyclase Inhibitors/immunologyAdenylyl Cyclase Inhibitors/isolation & purificationAdenylyl Cyclase Inhibitors/metabolismAdenylyl Cyclase Inhibitors/pharmacokineticsAdenylyl Cyclase Inhibitors/pharmacologyAdenylyl Cyclase Inhibitors/poisoningAdenylyl Cyclase Inhibitors/radiation effectsAdenylyl Cyclase Inhibitors/standardsAdenylyl Cyclase Inhibitors/supply & distributionAdenylyl Cyclase Inhibitors/therapeutic useAdenylyl Cyclase Inhibitors/toxicityAdenylyl Cyclase Inhibitors/urineAdenylyl Cyclase Inhibitors/chemistry
hasDescriptor
9-(tetrahydro-2-furyl)-adenine1H-3-benzazepin-7-ol, 8-bromo-2,3,4,5-tetrahydro-3-methyl-5-phenyl-7,8-dihydroxy-N,N-didesmethylchlorpromazine7,8-dioxo-N,N-didesmethylchlorpromazineethyl 5-aminopyrazolo(1,5-a)quinazoline-3-carboxylate2',5'-dideoxy-2-fluoroadenosine2',5'-dideoxy-2,5'-difluoroadenosine5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol2',3'-O-(N-methylanthraniloyl)inosine 5'-triphosphate
pharmacologicalAction
allowableQualifier
broaderDescriptor
dateCreated
2015-07-01
dateEstablished
2016-01-01
dateRevised
2015-04-02
historyNote
2016
@en
identifier
D000067956
preferredConcept
preferredTerm
previousIndexing
Adenylyl Cyclase/antagonists & inhibitors (1968-2015)
@en
publicMeSHNote
2016
@en
treeNumber
label
Adenylyl Cyclase Inhibitors
@en